Neurosterix
Boston, United States· Est.
Neurosterix develops novel therapeutics targeting neurosteroid pathways for neurological and neuropsychiatric disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $63M
About
Neurosterix develops novel therapeutics targeting neurosteroid pathways for neurological and neuropsychiatric disorders.
Neuroscience
Funding History
1Total raised:$63M
Venture$63M